Clinical Trial Update: Evaluation of Antiplatelet Effects of Different Dosages of Aspirin in Type 2 Diabetic Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating antiplatelet effects of different aspirin dosages in patients with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Karolinska Institutet | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED